Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
608,938,268
-
Share change
-
+38,964,685
-
Total reported value
-
$9,893,752,500
-
Put/Call ratio
-
19%
-
Price per share
-
$16.25
-
Number of holders
-
527
-
Value change
-
+$636,329,276
-
Number of buys
-
268
-
Number of sells
-
175
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2024
As of 30 Jun 2024,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
527 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
608,938,268 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, Ion Asset Management Ltd., Clal Insurance Enterprises Holdings Ltd, Migdal Insurance & Financial Holdings Ltd., MENORA MIVTACHIM HOLDINGS LTD., Lingotto Investment Management LLP, Phoenix Holdings Ltd., Slate Path Capital LP, and STATE STREET CORP.
This page lists
528
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.